FDA
approval
· 2021-08-06
FDA Approved: XADAGO — Supplemental Application (MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for XADAGO (safinamide mesylate) submitted by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc., exp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for XADAGO (SAFINAMIDE MESYLATE)